165 related articles for article (PubMed ID: 37823932)
21. Inverse Relation between MxA Gene Expression and Age in Multiple Sclerosis Patients Reveals a Gender Difference in Response to Interferon Therapy.
Taheri M; Mirinezhad M; Omrani MD; Sajjadi E; Inoko H; Sayad A
Iran J Allergy Asthma Immunol; 2017 Feb; 16(1):21-27. PubMed ID: 28417621
[TBL] [Abstract][Full Text] [Related]
22. Granzyme B + CD8 + T cells with terminal differentiated effector signature determine multiple sclerosis progression.
Shi Z; Wang X; Wang J; Chen H; Du Q; Lang Y; Kong L; Luo W; Qiu Y; Zhang Y; Li C; Wen D; Yao J; Cheng X; Cai L; Lin X; Wang R; Mou Z; Li S; Liu D; Zhou H; Zhou H; Yang M
J Neuroinflammation; 2023 Jun; 20(1):138. PubMed ID: 37268957
[TBL] [Abstract][Full Text] [Related]
23. Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
Romme Christensen J; Börnsen L; Hesse D; Krakauer M; Sørensen PS; Søndergaard HB; Sellebjerg F
J Neuroinflammation; 2012 Sep; 9():215. PubMed ID: 22978757
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-22 Level in Patients with Multiple Sclerosis and Its Relationship with Vitamin D and Vitamin D Receptor Levels.
Khedr AMB; Shaker OG; Hassan A; Hussein M; Kamal YS; Azouz TA
Neuroimmunomodulation; 2022; 29(2):128-134. PubMed ID: 34537762
[TBL] [Abstract][Full Text] [Related]
25. Involvement of cytotoxic Eomes-expressing CD4
Raveney BJE; Sato W; Takewaki D; Zhang C; Kanazawa T; Lin Y; Okamoto T; Araki M; Kimura Y; Sato N; Sano T; Saito Y; Oki S; Yamamura T
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836594
[TBL] [Abstract][Full Text] [Related]
26. Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients.
Nguyen LT; Ramanathan M; Weinstock-Guttman B; Baier M; Brownscheidle C; Jacobs LD
J Neurol Sci; 2003 May; 209(1-2):93-9. PubMed ID: 12686409
[TBL] [Abstract][Full Text] [Related]
27. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
[TBL] [Abstract][Full Text] [Related]
28. Differential microRNA expression in blood in multiple sclerosis.
Søndergaard HB; Hesse D; Krakauer M; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Dec; 19(14):1849-57. PubMed ID: 23773985
[TBL] [Abstract][Full Text] [Related]
29. Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity--preliminary study.
Kacperska MJ; Jastrzebski K; Tomasik B; Walenczak J; Konarska-Krol M; Glabinski A
J Mol Neurosci; 2015 May; 56(1):154-63. PubMed ID: 25487315
[TBL] [Abstract][Full Text] [Related]
30. A comparison of serum inflammatory parameters in progressive forms of multiple sclerosis.
Nowak-Kiczmer M; Niedziela N; Czuba ZP; Sowa P; Wierzbicki K; Lubczyński M; Adamczyk-Sowa M
Mult Scler Relat Disord; 2023 Nov; 79():105004. PubMed ID: 37738756
[TBL] [Abstract][Full Text] [Related]
31. Cytokine profile in relapsing‑remitting multiple sclerosis patients and the association between progression and activity of the disease.
Kallaur AP; Oliveira SR; Colado Simão AN; Delicato de Almeida ER; Kaminami Morimoto H; Lopes J; de Carvalho Jennings Pereira WL; Marques Andrade R; Muliterno Pelegrino L; Donizete Borelli S; Kaimen-Maciel DR; Reiche EM
Mol Med Rep; 2013 Mar; 7(3):1010-20. PubMed ID: 23292766
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of humoral immunity, iron homeostasis, and lipid metabolism is associated with multiple sclerosis progression.
Wang Q; Wu Q; Yang J; Saad A; Mills E; Dowling C; Lundy S; Mao-Draayer Y
Mult Scler Relat Disord; 2023 Nov; 79():105020. PubMed ID: 37806231
[TBL] [Abstract][Full Text] [Related]
33. Expression levels of IL-17/IL-23 cytokine-targeting microRNAs 20, 21, 26, 155, and Let-7 in patients with relapsing-remitting multiple sclerosis.
Balkan E; Bilge N
Neurol Res; 2021 Sep; 43(9):778-783. PubMed ID: 34130607
[No Abstract] [Full Text] [Related]
34. Genetic Alterations in Patients with Two Clinical Phenotypes of Multiple Sclerosis.
Feliciano LM; Sávio ALV; de Castro Marcondes JP; da Silva GN; Salvadori DMF
J Mol Neurosci; 2020 Jan; 70(1):120-130. PubMed ID: 31686392
[TBL] [Abstract][Full Text] [Related]
35. The effect of retinyl-palmitate on the level of pro and anti-inflammatory cytokines in multiple sclerosis patients: A randomized double blind clinical trial.
Bitarafan S; Mohammadpour Z; Jafarirad S; Harirchian MH; Yekaninejad MS; Saboor-Yaraghi AA
Clin Neurol Neurosurg; 2019 Feb; 177():101-105. PubMed ID: 30640138
[TBL] [Abstract][Full Text] [Related]
36. Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease.
Emamgholipour S; Eshaghi SM; Hossein-nezhad A; Mirzaei K; Maghbooli Z; Sahraian MA
PLoS One; 2013; 8(10):e76555. PubMed ID: 24098530
[TBL] [Abstract][Full Text] [Related]
37. Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
Ratzer R; Søndergaard HB; Christensen JR; Börnsen L; Borup R; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Dec; 19(14):1841-8. PubMed ID: 24085340
[TBL] [Abstract][Full Text] [Related]
38. Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology.
Zheleznyakova GY; Piket E; Needhamsen M; Hagemann-Jensen M; Ekman D; Han Y; James T; Khademi M; Al Nimer F; Scicluna P; Huang J; Kockum I; Faridani OR; Olsson T; Piehl F; Jagodic M
Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33879606
[TBL] [Abstract][Full Text] [Related]
39. Relationship between miRNA-21, miRNA-155, and miRNA-182 expression and inflammatory factors in cerebrospinal fluid from patients with multiple sclerosis.
Shademan B; Zakeri M; Abbasi S; Biray Avci C; Karamad V; Sogutlu F; Laghousi D; Nouri M; Hassanpour M; Nourazarian A
Clin Neurol Neurosurg; 2023 Sep; 232():107873. PubMed ID: 37453285
[TBL] [Abstract][Full Text] [Related]
40. Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns.
Salehi Z; Doosti R; Beheshti M; Janzamin E; Sahraian MA; Izad M
PLoS One; 2016; 11(7):e0159565. PubMed ID: 27467597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
